Terumo Corporation (TRUMY)
OTCMKTS · Delayed Price · Currency is USD
16.35
+0.20 (1.24%)
Jul 21, 2025, 3:27 PM EDT
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2012 - 2020 |
Cardiac and Vascular Company | 624.36B | Log In | Log In | Log In | Log In | Upgrade |
Cardiac and Vascular Company Growth | 12.35% | Log In | Log In | Log In | Log In | Upgrade |
Medical Care Solutions Company | 211.24B | Log In | Log In | Log In | Log In | Upgrade |
Medical Care Solutions Company Growth | 6.92% | Log In | Log In | Log In | Log In | Upgrade |
Blood and Cell Technologies Company | 200.28B | Log In | Log In | Log In | Log In | Upgrade |
Blood and Cell Technologies Company Growth | 18.98% | Log In | Log In | Log In | Log In | Upgrade |
Other | 1.00M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Adjustments from | 298.00M | Log In | Log In | Log In | Log In | Upgrade |
Adjustments from Growth | 20.16% | Log In | Log In | Log In | Log In | Upgrade |
Other | 1.00M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2012 - 2020 |
Other | 3.00M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Americas | 395.65B | Log In | Log In | Log In | Log In | Upgrade |
Americas Growth | 20.63% | Log In | Log In | Log In | Log In | Upgrade |
Europe | 218.29B | Log In | Log In | Log In | Log In | Upgrade |
Europe Growth | 13.99% | Log In | Log In | Log In | Log In | Upgrade |
China | 84.97B | Log In | Log In | Log In | Log In | Upgrade |
China Growth | 7.00% | Log In | Log In | Log In | Log In | Upgrade |
Asia and Others | 120.05B | Log In | Log In | Log In | Log In | Upgrade |
Asia and Others Growth | 7.34% | Log In | Log In | Log In | Log In | Upgrade |
Japan | 217.21B | Log In | Log In | Log In | Log In | Upgrade |
Japan Growth | 2.88% | Log In | Log In | Log In | Log In | Upgrade |
Other | 3.00M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other
Fiscal year is April - March.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2012 - 2020 |
Cardiac and Vascular Company Adjusted Operating Profit | 154.68B | Log In | Log In | Log In | Log In | Upgrade |
Cardiac and Vascular Company Adjusted Operating Profit Growth | 15.38% | Log In | Log In | Log In | Log In | Upgrade |
Medical Care Solutions Company Adjusted Operating Profit | 22.99B | Log In | Log In | Log In | Log In | Upgrade |
Medical Care Solutions Company Adjusted Operating Profit Growth | -0.53% | Log In | Log In | Log In | Log In | Upgrade |
Blood and Cell Technologies Company Adjusted Operating Profit | 26.48B | Log In | Log In | Log In | Log In | Upgrade |
Blood and Cell Technologies Company Adjusted Operating Profit Growth | 164.44% | Log In | Log In | Log In | Log In | Upgrade |
Adjustments from Adjusted Operating Profit | -712.00M | Log In | Log In | Log In | Log In | Upgrade |
Adjustments from Adjusted Operating Profit Growth | 171.81% | Log In | Log In | Log In | Log In | Upgrade |
Cardiac and Vascular Company Production Result | 620.90B | Log In | Log In | Log In | Log In | Upgrade |
Cardiac and Vascular Company Production Result Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Medical Care Solutions Company Production Result | 197.08B | Log In | Log In | Log In | Log In | Upgrade |
Medical Care Solutions Company Production Result Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Blood and Cell Technologies Company Production Result | 205.67B | Log In | Log In | Log In | Log In | Upgrade |
Blood and Cell Technologies Company Production Result Growth | - | Log In | Log In | Log In | Log In | Upgrade |